{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:18:50Z","timestamp":1773292730357,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":3476,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.exphem.2012.08.003","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T14:01:11Z","timestamp":1344607271000},"page":"1043-1054.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Valproic acid triggers erythro\/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression"],"prefix":"10.1016","volume":"40","author":[{"given":"Roberta","family":"Zini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruggiero","family":"Norfo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Salati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Pennucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Sacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Carboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Battista","family":"Ceccherelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Tagliafico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Manfredini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2012.08.003_bib1","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.1063443","article-title":"Epigenetic reprogramming in mammalian development","volume":"293","author":"Reik","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.exphem.2012.08.003_bib2","doi-asserted-by":"crossref","unstructured":"Gibney ER, Nolan CM. Epigenetics and gene expression. Heredity (Edinb). 2010;105:4\u221213.","DOI":"10.1038\/hdy.2010.54"},{"key":"10.1016\/j.exphem.2012.08.003_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/CAD.0b013e32833a4352","article-title":"Epigenetic tools in potential anticancer therapy","volume":"21","author":"Sebova","year":"2010","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.exphem.2012.08.003_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mrrev.2008.02.004","article-title":"Epigenetic interplay between histone modifications and DNA methylation in gene silencing","volume":"659","author":"Vaissiere","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.exphem.2012.08.003_bib5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jcb.22185","article-title":"Histone deacetylase inhibitors: potential in cancer therapy","volume":"107","author":"Marks","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.exphem.2012.08.003_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s12094-008-0221-x","article-title":"Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer","volume":"10","author":"Martinez-Iglesias","year":"2008","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.exphem.2012.08.003_bib7","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1182\/blood-2003-07-2431","article-title":"Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A","volume":"103","author":"Milhem","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.08.003_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.exphem.2005.10.002","article-title":"Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents","volume":"34","author":"Araki","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2012.08.003_bib9","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1182\/blood-2006-07-035287","article-title":"Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential","volume":"109","author":"Araki","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.08.003_bib10","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1158\/0008-5472.CAN-04-3011","article-title":"Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells","volume":"65","author":"Bug","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2012.08.003_bib11","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1158\/0008-5472.CAN-04-3063","article-title":"Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells","volume":"65","author":"De Felice","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2012.08.003_bib12","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1182\/blood-2011-08-375386","article-title":"The combination of valproic acid and lithium delays hematopoietic stem\/progenitor cell differentiation","volume":"119","author":"Walasek","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.08.003_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0609.2008.01169.x","article-title":"Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum-free conditions","volume":"82","author":"Seet","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.exphem.2012.08.003_bib14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/scd.2008.0235","article-title":"Valproic acid increases CXCR4 expression in hematopoietic stem\/progenitor cells by chromatin remodeling","volume":"18","author":"Gul","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.exphem.2012.08.003_bib15","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3324\/haematol.2009.008870","article-title":"Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation","volume":"95","author":"Bartels","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2012.08.003_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.exphem.2010.03.019","article-title":"A potential activity of valproic acid in the stimulation of interleukin-3-mediated megakaryopoiesis and erythropoiesis","volume":"38","author":"Liu","year":"2010","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2012.08.003_bib17","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1182\/blood-2010-10-314567","article-title":"Chromatin-modifying agents promote the ex\u00a0vivo production of functional human erythroid progenitor cells","volume":"117","author":"Chaurasia","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.08.003_bib18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/35895","article-title":"Role of the histone deacetylase complex in acute promyelocytic leukaemia","volume":"391","author":"Lin","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2012.08.003_bib19","doi-asserted-by":"crossref","first-page":"10860","DOI":"10.1073\/pnas.95.18.10860","article-title":"ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR\/mSin3\/HDAC1 complex","volume":"95","author":"Wang","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2012.08.003_bib20","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action","volume":"26","author":"Xu","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2012.08.003_bib21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cncr.22891","article-title":"Valproic acid for the treatment of myeloid malignancies","volume":"110","author":"Kuendgen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2012.08.003_bib22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.exphem.2012.08.003_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2012.08.003_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.21552","article-title":"The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia","volume":"106","author":"Kuendgen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2012.08.003_bib25","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1182\/blood-2003-12-4333","article-title":"Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid","volume":"104","author":"Kuendgen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.08.003_bib26","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1182\/blood-2007-03-078576","article-title":"Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome","volume":"110","author":"Soriano","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.08.003_bib27","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1158\/0008-5472.CAN-05-2726","article-title":"Sequential valproic acid\/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia","volume":"66","author":"Cimino","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2012.08.003_bib28","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1002\/cncr.23433","article-title":"Valproic acid for the treatment of myeloid malignancies","volume":"112","author":"Shah","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2012.08.003_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s13148-011-0031-9","article-title":"Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid","volume":"2","author":"Kuendgen","year":"2011","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.exphem.2012.08.003_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00277-010-1090-2","article-title":"Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial","volume":"90","author":"Candelaria","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2012.08.003_bib31","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1182\/blood-2010-10-314567","article-title":"Chromatin-modifying agents promote the ex\u00a0vivo production of functional human erythroid progenitor cells","volume":"117","author":"Chaurasia","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.08.003_bib32","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2009-09-241752","article-title":"Gfi-1B controls human erythroid and megakaryocytic differentiation by regulating TGF-beta signaling at the bipotent erythro-megakaryocytic progenitor stage","volume":"115","author":"Randrianarison-Huetz","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.08.003_bib33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.stem.2008.01.013","article-title":"MLLT3 regulates early human erythroid and megakaryocytic cell fate","volume":"2","author":"Pina","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2012.08.003_bib34","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1182\/blood-2009-08-238311","article-title":"c-myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression","volume":"116","author":"Bianchi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.08.003_bib35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1182\/blood.V97.1.154","article-title":"Actin reorganization and proplatelet formation in murine megakaryocytes: the role of protein kinase calpha","volume":"97","author":"Rojnuckarin","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.08.003_bib36","first-page":"291","article-title":"A novel aspect of the maturational step of megakaryocytes in thrombopoiesis: bundle formation of microtubules in megakaryocytes","volume":"24","author":"Tajika","year":"1996","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2012.08.003_bib37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.cb.05.110189.002235","article-title":"Biogenesis of the red blood cell membrane-skeleton and the control of erythroid morphogenesis","volume":"5","author":"Lazarides","year":"1989","journal-title":"Annu Rev Cell Biol"},{"key":"10.1016\/j.exphem.2012.08.003_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.me.39.020188.000543","article-title":"The erythroid membrane skeleton: expression and assembly during erythropoiesis","volume":"39","author":"Woods","year":"1988","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.exphem.2012.08.003_bib39","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1101\/gad.13.14.1847","article-title":"A GATA-2\/estrogen receptor chimera functions as a ligand-dependent negative regulator of self-renewal","volume":"13","author":"Heyworth","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2012.08.003_bib40","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1182\/blood-2002-04-1177","article-title":"GATA-2\/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins","volume":"100","author":"Ezoe","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.08.003_bib41","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1073\/pnas.0607894104","article-title":"Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells","volume":"104","author":"Jankovic","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2012.08.003_bib42","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1634\/stemcells.2005-0439","article-title":"Fibroblast growth factor-1 and -2 preserve long-term repopulating ability of hematopoietic stem cells in serum-free cultures","volume":"24","author":"Yeoh","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2012.08.003_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/stem.200011","article-title":"ABC transporters as phenotypic markers and functional regulators of stem cells","volume":"20","author":"Bunting","year":"2002","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2012.08.003_bib44","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1038\/sj.emboj.7600702","article-title":"GATA-1 forms distinct activating and repressive complexes in erythroid cells","volume":"24","author":"Rodriguez","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2012.08.003_bib45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1357-2725(97)00135-0","article-title":"The NF-E2 transcription factor","volume":"30","author":"Andrews","year":"1998","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.exphem.2012.08.003_bib46","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1074\/jbc.M109.030296","article-title":"Targets of the Tal1 transcription factor in erythrocytes: E2 ubiquitin conjugase regulation by Tal1","volume":"285","author":"Lausen","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2012.08.003_bib47","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1017\/S1462399408000860","article-title":"Survival and proliferative roles of erythropoietin beyond the erythroid lineage","volume":"10","author":"Noguchi","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.exphem.2012.08.003_bib48","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0006-291X(02)00330-3","article-title":"A role of EphB4 receptor and its ligand, ephrin-B2, in erythropoiesis","volume":"293","author":"Suenobu","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2012.08.003_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.V84.1.59.59","article-title":"Mast cell growth factor modulates CD36 antigen expression on erythroid progenitors from human bone marrow and peripheral blood associated with ongoing differentiation","volume":"84","author":"de Wolf","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.08.003_bib50","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jcb.22142","article-title":"Megakaryocytic programming by a transcriptional regulatory loop: a circle connecting RUNX1, GATA-1, and P-TEFb","volume":"107","author":"Goldfarb","year":"2009","journal-title":"J Cell Biochem"},{"issue":"suppl 2","key":"10.1016\/j.exphem.2012.08.003_bib51","first-page":"79","article-title":"Transcription factor GATA-1 in megakaryocyte development","volume":"16","author":"Orkin","year":"1998","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2012.08.003_bib52","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1182\/blood.V97.7.1982","article-title":"CD9 and megakaryocyte differentiation","volume":"97","author":"Clay","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.08.003_bib53","first-page":"1934","article-title":"Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice","volume":"118","author":"Ghosh","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2012.08.003_bib54","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2141.2004.05326.x","article-title":"Induction of CCAAT\/enhancer binding protein-delta by cytokinins, but not by retinoic acid, during granulocytic differentiation of human myeloid leukaemia cells","volume":"128","author":"Ishii","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2012.08.003_bib55","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood.V60.3.618.618","article-title":"Cellular and extracellular myeloperoxidase in pyogenic inflammation","volume":"60","author":"Bradley","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.08.003_bib56","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/med.10017","article-title":"Anti-tumor mechanisms of valproate: a novel role for an old drug","volume":"22","author":"Blaheta","year":"2002","journal-title":"Med Res Rev"},{"key":"10.1016\/j.exphem.2012.08.003_bib57","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2012.08.003_bib58","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1537-2995.2005.00174.x","article-title":"Establishment and optimization of a flow cytometric method for evaluation of viability of CD34+ cells after cryopreservation and comparison with trypan blue exclusion staining","volume":"45","author":"Humpe","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.exphem.2012.08.003_bib59","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1177\/26.11.82573","article-title":"Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures. Some pitfalls in staining and data analysis","volume":"26","author":"Fried","year":"1978","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.exphem.2012.08.003_bib60","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1634\/stemcells.2004-0265","article-title":"The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment","volume":"23","author":"Manfredini","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2012.08.003_bib61","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1182\/blood-2009-08-238311","article-title":"c-myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression","volume":"116","author":"Bianchi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.08.003_bib62","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/scd.2008.0235","article-title":"Valproic acid increases CXCR4 expression in hematopoietic stem\/progenitor cells by chromatin remodeling","volume":"18","author":"Gul","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.exphem.2012.08.003_bib63","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/sj.onc.1208301","article-title":"Myb proteins regulate the expression of diverse target genes","volume":"24","author":"Lang","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2012.08.003_bib64","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1634\/stemcells.2007-0597","article-title":"Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells","volume":"26","author":"Salati","year":"2008","journal-title":"Stem Cells"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X1200344X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X1200344X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:30:03Z","timestamp":1759566603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X1200344X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":64,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0301472X1200344X"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2012.08.003","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid triggers erythro\/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2012.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}